Aspen Aerogels (ASPN) to Release Earnings on Thursday

Aspen Aerogels (NYSE:ASPNGet Rating) will be announcing its earnings results before the market opens on Thursday, April 28th. Analysts expect the company to announce earnings of ($0.47) per share for the quarter. Aspen Aerogels has set its FY 2022 guidance at $-2.070-$-1.950 EPS.Investors interested in listening to the company’s conference call can do so using this link.

Aspen Aerogels (NYSE:ASPNGet Rating) last announced its quarterly earnings data on Thursday, February 17th. The construction company reported ($0.50) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.30) by ($0.20). The company had revenue of $31.48 million during the quarter, compared to analyst estimates of $35.71 million. Aspen Aerogels had a negative net margin of 30.50% and a negative return on equity of 33.70%. During the same period in the prior year, the firm earned ($0.23) earnings per share. On average, analysts expect Aspen Aerogels to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Shares of NYSE ASPN opened at $26.17 on Thursday. The stock has a market capitalization of $869.73 million, a PE ratio of -21.99 and a beta of 1.77. The business has a fifty day moving average price of $29.96 and a two-hundred day moving average price of $41.33. Aspen Aerogels has a fifty-two week low of $16.64 and a fifty-two week high of $65.99.

In other Aspen Aerogels news, Director Robert M. Gervis bought 135,870 shares of the business’s stock in a transaction that occurred on Tuesday, March 22nd. The shares were bought at an average price of $33.12 per share, for a total transaction of $4,500,014.40. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, major shareholder Koch Industries Inc purchased 1,791,986 shares of the company’s stock in a transaction that occurred on Monday, March 28th. The shares were purchased at an average cost of $27.90 per share, for a total transaction of $49,996,409.40. The disclosure for this purchase can be found here. 13.30% of the stock is owned by corporate insiders.

Several institutional investors have recently modified their holdings of ASPN. Marshall Wace LLP purchased a new stake in shares of Aspen Aerogels in the fourth quarter worth approximately $141,000. BNP Paribas Arbitrage SA increased its position in shares of Aspen Aerogels by 457.3% during the third quarter. BNP Paribas Arbitrage SA now owns 3,734 shares of the construction company’s stock valued at $172,000 after acquiring an additional 3,064 shares during the last quarter. Two Sigma Advisers LP purchased a new stake in shares of Aspen Aerogels during the third quarter valued at approximately $216,000. Legal & General Group Plc increased its position in shares of Aspen Aerogels by 279.5% during the fourth quarter. Legal & General Group Plc now owns 8,714 shares of the construction company’s stock valued at $434,000 after acquiring an additional 6,418 shares during the last quarter. Finally, Bank of America Corp DE grew its holdings in Aspen Aerogels by 122.1% during the fourth quarter. Bank of America Corp DE now owns 14,417 shares of the construction company’s stock valued at $718,000 after purchasing an additional 7,926 shares during the period. 83.46% of the stock is owned by hedge funds and other institutional investors.

A number of equities analysts have recently commented on the company. Piper Sandler lowered their price target on Aspen Aerogels from $72.00 to $68.00 and set an “overweight” rating for the company in a report on Friday, February 18th. HC Wainwright lowered their price target on Aspen Aerogels from $65.00 to $45.00 and set a “buy” rating for the company in a report on Friday, February 18th. Benchmark lowered their price target on Aspen Aerogels from $70.00 to $60.00 in a report on Friday, February 18th. B. Riley reissued a “top pick” rating on shares of Aspen Aerogels in a report on Monday, January 3rd. Finally, Canaccord Genuity Group lowered their price target on Aspen Aerogels from $52.00 to $47.00 in a report on Friday, February 18th. One analyst has rated the stock with a sell rating, nine have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $51.18.

Aspen Aerogels Company Profile (Get Rating)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets in the United States, Asia, Canada, Europe, and Latin America. The company offers PyroThin thermal barriers for use in lithium-ion batteries in electric vehicles and energy storage industries; Pyrogel XTE that reduces the risk of corrosion under insulation in energy infrastructure operating systems; Pyrogel HPS for applications within the power generation market; Pyrogel XTF to provide protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; and Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production.

See Also

Earnings History for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.